Profile
Emily Minkow is currently the Director at Stylus Medicine, Inc. and a Venture Partner at RA Capital Management LP (Private Equity).
She was previously the Chief Business Officer at Prevail Therapeutics, Inc. and the Executive Director-Business Development at Celgene Corp.
Ms. Minkow received her undergraduate degree from Princeton University and her MBA from Harvard Business School.
Emily Minkow active positions
| Companies | Position | Start |
|---|---|---|
| PREVAIL THERAPEUTICS INC. | Corporate Officer/Principal | 01/11/2018 |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement. | Private Equity Investor | 01/01/2022 |
Stylus Medicine, Inc.
Stylus Medicine, Inc. Medical SpecialtiesHealth Technology Develops therapies | Director/Board Member | - |
Former positions of Emily Minkow
| Companies | Position | End |
|---|---|---|
| CELGENE | Corporate Officer/Principal | 01/10/2017 |
Training of Emily Minkow
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prevail Therapeutics, Inc.
Prevail Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics for neurodegenerative diseases | Health Technology |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement. | Finance |
Stylus Medicine, Inc.
Stylus Medicine, Inc. Medical SpecialtiesHealth Technology Develops therapies | Health Technology |
- Stock Market
- Insiders
- Emily Minkow
















